LORLATINIB for Lung neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 810 adverse event reports in the FDA FAERS database where LORLATINIB was used for Lung neoplasm malignant.

Most Reported Side Effects for LORLATINIB

Side Effect	Reports	%	Deaths	Hosp.
Death	1,050	19.1%	1,047	74
Neoplasm progression	633	11.5%	278	155
Off label use	394	7.2%	97	87
Weight increased	306	5.6%	17	46
Hallucination	290	5.3%	21	56
Blood cholesterol increased	281	5.1%	32	47
Dyspnoea	223	4.1%	49	113
Oedema peripheral	198	3.6%	29	62
Oedema	195	3.5%	17	36
Fatigue	188	3.4%	44	49
Peripheral swelling	164	3.0%	21	30
Cognitive disorder	158	2.9%	11	31
Hypercholesterolaemia	157	2.9%	19	43
Blood triglycerides increased	145	2.6%	19	35
Neuropathy peripheral	142	2.6%	3	17